Bayer floats animal health merger with Lilly spinoff Elanco: report

Bayer’s for-sale animal health unit has been stirring up interest among private equity players—but the German pharma may have another buyer in mind.

The company has approached Elanco, spun off by Eli Lilly last year, about a potential tie-up between the two, Reuters reports, citing three unnamed sources.